Anna Karlsson

8.8k total citations · 2 hit papers
186 papers, 7.1k citations indexed

About

Anna Karlsson is a scholar working on Molecular Biology, Infectious Diseases and Virology. According to data from OpenAlex, Anna Karlsson has authored 186 papers receiving a total of 7.1k indexed citations (citations by other indexed papers that have themselves been cited), including 125 papers in Molecular Biology, 51 papers in Infectious Diseases and 34 papers in Virology. Recurrent topics in Anna Karlsson's work include Biochemical and Molecular Research (63 papers), HIV/AIDS drug development and treatment (48 papers) and HIV Research and Treatment (33 papers). Anna Karlsson is often cited by papers focused on Biochemical and Molecular Research (63 papers), HIV/AIDS drug development and treatment (48 papers) and HIV Research and Treatment (33 papers). Anna Karlsson collaborates with scholars based in Sweden, Belgium and Spain. Anna Karlsson's co-authors include Magnus Johansson, Erik De Clercq, An R. Van Rompay, Jan Balzarini, Marı́a-José Camarasa, Jan Balzarini, Staffan Arvidson, Nicola Solaroli, Ana San‐Félix and Carlo Federico Perno and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Biological Chemistry.

In The Last Decade

Anna Karlsson

183 papers receiving 6.9k citations

Hit Papers

1,2,3-Triazole-[2,5-Bis-O... 1994 2026 2004 2015 1994 1997 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. 1,2,3-Triazole-[2,5-Bis-O-(tert-butyldimethylsilyl)-.beta.-D-ribofuranosyl]-3'-spiro-5''-(4''-amino-1'',2''-oxathiole 2'',2''-dioxide) (TSAO) Analogs: Synthesis and Anti-HIV-1 Activity
    1994 700 citations Sonsoles Velázquez, Ana San‐Félix et al. profile →
  2. Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype
    1997 525 citations Anna Karlsson et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Anna Karlsson 3.7k 2.3k 1.7k 1.2k 1.0k 186 7.1k
José Alcamı́ 2.4k 0.7× 1.7k 0.8× 2.8k 1.6× 391 0.3× 1.1k 1.1× 211 6.9k
Christine Debouck 3.7k 1.0× 2.0k 0.9× 2.7k 1.5× 530 0.5× 668 0.7× 82 6.9k
José A. Esté 2.3k 0.6× 2.8k 1.2× 4.2k 2.4× 769 0.7× 1.2k 1.2× 177 7.4k
Raffaele De Francesco 5.1k 1.4× 2.7k 1.2× 783 0.4× 800 0.7× 4.3k 4.2× 155 12.2k
Amy K. Patick 2.5k 0.7× 2.3k 1.0× 1.5k 0.8× 655 0.6× 1.3k 1.2× 74 6.3k
Hui Zhang 4.8k 1.3× 2.3k 1.0× 2.6k 1.5× 273 0.2× 1.9k 1.9× 276 10.2k
Antero G. So 3.7k 1.0× 1.3k 0.6× 1.1k 0.6× 204 0.2× 426 0.4× 64 5.7k
Thomas A. Krenitsky 3.3k 0.9× 1.3k 0.5× 318 0.2× 483 0.4× 1.5k 1.5× 96 5.0k
Licia Tomei 3.9k 1.1× 1.5k 0.7× 453 0.3× 258 0.2× 2.2k 2.2× 92 7.9k
Karl Y. Hostetler 3.3k 0.9× 1.4k 0.6× 1.2k 0.7× 345 0.3× 2.3k 2.3× 183 7.0k

Countries citing papers authored by Anna Karlsson

Since Specialization
Citations

This map shows the geographic impact of Anna Karlsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Karlsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Karlsson more than expected).

Fields of papers citing papers by Anna Karlsson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Karlsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Karlsson. The network helps show where Anna Karlsson may publish in the future.

Co-authorship network of co-authors of Anna Karlsson

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Karlsson. A scholar is included among the top collaborators of Anna Karlsson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Karlsson. Anna Karlsson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Prunty, Helen, John R. Counsell, Anna Karlsson, et al.. (2024). Gene therapy prevents hepatic mitochondrial dysfunction in murine deoxyguanosine kinase deficiency. Molecular Therapy — Methods & Clinical Development. 33(1). 101397–101397. 1 indexed citations
2.
Rydzak, Thomas, et al.. (2023). The Roles of Nicotinamide Adenine Dinucleotide Phosphate Reoxidation and Ammonium Assimilation in the Secretion of Amino Acids as Byproducts of Clostridium thermocellum. Applied and Environmental Microbiology. 89(1). e0175322–e0175322. 5 indexed citations
3.
Karlsson, Anna, et al.. (2022). Subjective and objective evaluation of masticatory function in patients with bimaxillary implant‐supported prostheses. Journal of Oral Rehabilitation. 50(2). 140–149. 15 indexed citations
4.
Zhao, Qian, Xiaoshan Zhou, Raoul Kuiper, Sophie Curbo, & Anna Karlsson. (2022). Mitochondrial dysfunction is associated with lipid metabolism disorder and upregulation of angiotensin-converting enzyme 2. PLoS ONE. 17(6). e0270418–e0270418. 12 indexed citations
5.
Zhou, Xiaoshan, et al.. (2019). Age-related metabolic changes limit efficacy of deoxynucleoside-based therapy in thymidine kinase 2-deficient mice. EBioMedicine. 46. 342–355. 24 indexed citations
6.
Karlsson, Anna, Markus Ringnér, Martin Lauss, et al.. (2014). Genomic and Transcriptional Alterations in Lung Adenocarcinoma in Relation to Smoking History. Clinical Cancer Research. 20(18). 4912–4924. 23 indexed citations
7.
Karlsson, Anna, Mats Jönsson, Martin Lauss, et al.. (2014). Genome-wide DNA Methylation Analysis of Lung Carcinoma Reveals One Neuroendocrine and Four Adenocarcinoma Epitypes Associated with Patient Outcome. Clinical Cancer Research. 20(23). 6127–6140. 82 indexed citations
8.
Krishnan, Shuba, Xiaoshan Zhou, Raoul Kuiper, et al.. (2014). Long Term Expression of Drosophila melanogaster Nucleoside Kinase in Thymidine Kinase 2-deficient Mice with No Lethal Effects Caused by Nucleotide Pool Imbalances. Journal of Biological Chemistry. 289(47). 32835–32844. 7 indexed citations
9.
Curbo, Sophie, et al.. (2012). Is Trichloroacetic Acid an Insufficient Sample Quencher of Redox Reactions?. Antioxidants and Redox Signaling. 18(7). 795–799. 4 indexed citations
10.
Zhou, Xinwen, Nicola Solaroli, Mia Bjerke, et al.. (2008). Progressive loss of mitochondrial DNA in thymidine kinase 2-deficient mice. Human Molecular Genetics. 17(15). 2329–2335. 73 indexed citations
11.
Bjerke, Mia, Maribel Franco, Magnus Johansson, Jan Balzarini, & Anna Karlsson. (2008). Increased mitochondrial DNA copy-number in CEM cells resistant to delayed toxicity of 2′,3′-dideoxycytidine. Biochemical Pharmacology. 75(6). 1313–1321. 4 indexed citations
12.
Curbo, Sophie, Clotilde Lagier‐Tourenne, Rosalba Carrozzo, et al.. (2005). Human mitochondrial pyrophosphatase: cDNA cloning and analysis of the gene in patients with mtDNA depletion syndromes. Genomics. 87(3). 410–416. 24 indexed citations
13.
Schneider, Benoı̂t, et al.. (2002). Nucleotide affinity for a stable phosphorylated intermediate of nucleoside diphosphate kinase. Protein Science. 11(7). 1648–1656. 3 indexed citations
14.
Degrève, Bart, Erik De Clercq, Anna Karlsson, & Jan Balzarini. (1999). Efficacy of antiherpetic drugs in combined gene/chemotherapy of cancer is not affected by a specific nuclear or cytoplasmic compartmentation of herpes thymidine kinases. 3. 1 indexed citations
15.
Rompay, An R. Van, Magnus Johansson, & Anna Karlsson. (1999). Phosphorylation of Deoxycytidine Analog Monophosphates by UMP-CMP Kinase: Molecular Characterization of the Human Enzyme. Molecular Pharmacology. 56(3). 562–569. 3 indexed citations
16.
17.
Balzarini, Jan, Heidi Pelemans, María‐Jesús Pérez‐Pérez, et al.. (1996). Marked inhibitory activity of non-nucleoside reverse transcriptase inhibitors against human immunodeficiency virus type 1 when combined with (-)2',3'-dideoxy-3'-thiacytidine.. Molecular Pharmacology. 49(5). 882–890. 23 indexed citations
18.
Karlsson, Anna, et al.. (1996). Nucleoside Diphosphate Kinase. Journal of Biological Chemistry. 271(33). 19928–19934. 62 indexed citations
19.
20.
Balzarini, Jan, Anna Karlsson, & Erik De Clercq. (1993). Human immunodeficiency virus type 1 drug-resistance patterns with different 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine derivatives.. Molecular Pharmacology. 44(4). 694–701. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by José Alcamı́ Breakdown of academic impact, for papers by Christine Debouck Breakdown of academic impact, for papers by José A. Esté Breakdown of academic impact, for papers by Raffaele De Francesco Breakdown of academic impact, for papers by Amy K. Patick Breakdown of academic impact, for papers by Hui Zhang Breakdown of academic impact, for papers by Antero G. So Breakdown of academic impact, for papers by Thomas A. Krenitsky Breakdown of academic impact, for papers by Licia Tomei Breakdown of academic impact, for papers by Karl Y. Hostetler
Rankless by CCL
2026